Sanofi ( (SNY) ) has issued an announcement. Sanofi announced that the FDA has granted Breakthrough Therapy designation to tolebrutinib for treating non-relapsing secondary progressive multiple ...

Motherhood came knocking on Stephanie Handford’s door ten times. At just 21, she began welcoming foster children into her ...

Multiple sclerosis is a condition when the immune system attacks the protective sheath over nerve fibers, which interrupts ...

Exercise effectively eases fatigue and improves muscular fitness in MS patients, but the best type differs for each outcome, ...

Can simple diet and lifestyle changes keep your brain healthy? Do you have the power to prevent Alzheimer's disease and ...

The NTSB found that a ramp agent’s cognitive impairment led to their death from being ingested into an aircraft engine on ...

An international research team, including researchers at Karolinska Institutet, has mapped the genes expressed in the brain ...

You won't be able to get Attendance Allowance if you already get PIP or Disability Living Allowance (DLA) to pay for your ...

Bipolar cell dysfunction measured by electroretinography is a common finding in multiple sclerosis but it does not have ...

The holiday house at 1 Carlson Court is lighting and brightening up a township neighborhood. The Cooks’ holiday tradition includes officially lighting the exterior of their well-decorated home with a ...

The rate of frailty among patients with multiple sclerosis (MS) ranges from 17% to 66% among ambulatory patients, and frailty ...

Learn about MS Research Treatment and Education, a pioneering charity focused on advancing MS research who have recently merged with the MS Trust.